SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001129928-16-000017
Filing Date
2016-08-04
Accepted
2016-08-04 14:23:00
Documents
4
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 2016 SECOND QUARTER REPORT secondquarter20166k.htm 6-K 23994
2 2016 SECOND QUARTER INTERIM FINANCIAL STATEMENTS ex991interimfinancialstate.htm EX-99.1 353809
3 2016 SECOND QUARTER MD&A ex992-q22016mda.htm EX-99.2 272422
4 image0a01a02.jpg GRAPHIC 32654
  Complete submission text file 0001129928-16-000017.txt   696066
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 161806821
SIC: 2834 Pharmaceutical Preparations